These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1988631)

  • 1. Imaging human brain development with positron emission tomography.
    Chugani HT; Phelps ME
    J Nucl Med; 1991 Jan; 32(1):23-6. PubMed ID: 1988631
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron emission tomography in asphyxiated infants. Preliminary studies of regional cerebral glucose metabolism using 18F-FDG.
    Suhonen-Polvi H; Ruotsalainen U; Ahonen A; Haaparanta M; Aho K; Riikonen R; Kero P; Korvenranta H; Simell O; Wegelius U
    Acta Radiol Suppl; 1991; 376():173. PubMed ID: 1666770
    [No Abstract]   [Full Text] [Related]  

  • 3. Positron emission tomography in dementia.
    Friedland RP
    Semin Neurol; 1989 Dec; 9(4):338-44. PubMed ID: 2701778
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of blood flow on the positron-emission tomographic determination of substrate transport rates.
    Holden JE
    Circulation; 1985 Nov; 72(5 Pt 2):IV72-6. PubMed ID: 3876895
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tomographic measurement of human cerebral glucose metabolism].
    Iwasaki Y; Konishi J; Makada Y; Yonekura Y
    Nihon Rinsho; 1991 Jul; 49(7):1528-31. PubMed ID: 1886247
    [No Abstract]   [Full Text] [Related]  

  • 6. Positron emission tomography study of human brain functional development.
    Chugani HT; Phelps ME; Mazziotta JC
    Ann Neurol; 1987 Oct; 22(4):487-97. PubMed ID: 3501693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebral glucose metabolism in schizophrenia. Studies using positron-emission tomography].
    M'Rabet N; Lotstra F; Goldman S; Delvenne V; Mendlewicz J
    Acta Psychiatr Belg; 1991; 91(6):311-26. PubMed ID: 1670424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Positron emission tomography of the brain. A diagnostic technic on the threshold of clinical use].
    Heiss WD
    Dtsch Med Wochenschr; 1983 Jun; 108(23):887-90. PubMed ID: 6602042
    [No Abstract]   [Full Text] [Related]  

  • 9. Positron emission tomographic studies of regional cerebral glucose metabolism in idiopathic dystonia.
    Chase TN; Tamminga CA; Burrows H
    Adv Neurol; 1988; 50():237-41. PubMed ID: 3261115
    [No Abstract]   [Full Text] [Related]  

  • 10. [Functional brain study by radionuclide neuroimaging].
    Uemura K
    No To Shinkei; 1990 May; 42(5):425-34. PubMed ID: 2206632
    [No Abstract]   [Full Text] [Related]  

  • 11. Emission computed tomography in the study of human epilepsy.
    Kuhl DE; Engel J; Phelps ME
    Res Publ Assoc Res Nerv Ment Dis; 1983; 61():327-40. PubMed ID: 6601815
    [No Abstract]   [Full Text] [Related]  

  • 12. Brain imaging of glucose utilization in convulsive disorders.
    Engel J; Ackermann RF; Kuhl DE; Phelps ME
    Res Publ Assoc Res Nerv Ment Dis; 1985; 63():163-84. PubMed ID: 3927456
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucose.
    Blomqvist G; Stone-Elander S; Halldin C; Roland PE; Swahn CG; Haaparanta M; Solin O; Lindqvist M; Widén L
    Acta Radiol Suppl; 1991; 376():171-2. PubMed ID: 1666769
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of scopolamine on human brain glucose consumption.
    Blin J; Chase T
    Neuropsychopharmacology; 1995 May; 12(3):273-6. PubMed ID: 7612162
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of cerebrovascular disease with positron emission tomography: attempt of an in vivo model for treatment evaluation of brain glucose metabolism.
    Cinotti L; Croisile B; Laurent B; Le Bars D; Malbezin M; Mauguière F
    Eur Neurol; 1995; 35 Suppl 1():17-22. PubMed ID: 8529724
    [No Abstract]   [Full Text] [Related]  

  • 16. Images in neuroscience. Progressive dysarthria: structural and brain correlations.
    Selnes OA; Holcomb HH; Gordon B
    Am J Psychiatry; 1996 Mar; 153(3):309-10. PubMed ID: 8610816
    [No Abstract]   [Full Text] [Related]  

  • 17. Clarification of a fractional uptake concept.
    Thie JA
    J Nucl Med; 1995 Apr; 36(4):711-2. PubMed ID: 7699475
    [No Abstract]   [Full Text] [Related]  

  • 18. Positron emission tomography.
    Cohen RM; Semple WE; Gross M
    Psychiatr Clin North Am; 1986 Mar; 9(1):63-79. PubMed ID: 3515332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism.
    Martin WR; Stoessl AJ; Adam MJ; Ammann W; Bergstrom M; Harrop R; Laihinen A; Rogers JG; Ruth TJ; Sayre CI
    Adv Neurol; 1987; 45():95-8. PubMed ID: 3103398
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of fluorodeoxyglucose-positron emission tomography in the evaluation of seizure disorders.
    Theodore WH
    Semin Neurol; 1989 Dec; 9(4):301-6. PubMed ID: 2518339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.